admin

Your Money Is Being Spent to Promote Industry Propaganda

That’s right, not only are the government and the food and chemical technology industries fighting tooth and nail to prevent GMO labeling, your hard-earned tax dollars will also be spent on industry propaganda to “assure” you that genetically engineered (GE) foods are of no concern.

This joint effort by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA) is an outrage.

Instead of safeguarding environmental and human health, these agencies are simply supporting and promoting the industry agenda, regardless of the cost to society. Indeed, as noted in another recent article, the USDA has come under increasing scrutiny following charges of harassment and censorship of its own scientists.

Vermont Lawmakers Uphold GMO Labeling Law

The Grocery Manufacturers Association (GMA) and its ally, the Vermont Retail and Grocers Association, are also pressuring Vermont lawmakers to add a rider to the state’s must-pass budget bill.

The rider would delay the deadline for compliance with the state’s GMO labeling law, set to take effect July 1, pushing the deadline all the way back to January 1, 2018.

Clearly, this move has but one purpose, and that is to give these parties more time to convince Congress to implement federal regulations to preempt all state labeling laws, thereby preventing Vermont’s law from ever taking effect. As noted by the Organic Consumers Association:

“Vermont voters and lawmakers overwhelmingly supported Act 120, a law to require GMO labels. The governor signed it into law May 8, 2014. Monsanto and the GMA promptly sued to overturn it, but so far, the courts have refused to block the law…

Monsanto and the GMA have failed to convince enough U.S. Senators to preempt Vermont’s law. They’ve failed to get the votes they need for their DARK — Deny Americans the Right to Know — Act.

So they’re coming in the back door, using the Vermont Senate appropriations process — to delay the law, and buy themselves more time…

Vermont lawmakers claim they can’t hold up the state budget…just to protect the July 1 GMO labeling deadline. That’s just wrong. Vermont voters have waited long enough…Food companies have had ample time to prepare GMO labels…

Vermont lawmakers owe it to their constituents to uphold Vermont’s law and enforce it. Anything less is just pandering to big corporate interests.”

Several Companies Have Already Announced They Will Comply With Vermont Labeling Law

Campbell’s was the first company to announce it is ready to comply with the Vermont law and will begin labeling GMOs. Contrary to GMA scare tactic claims, the company also assured consumers the new label would not result in higher prices.5

Mars, Inc.6 Kellogg Company,7 ConAgra,8 and General Mills9 have since followed suit, announcing they too will comply by labeling all of their foods sold across the U.S. General Mills has also launched an online search tool10 to help you determine which of their products contain GMOs.

These companies are proof positive that the food industry does not need more time to comply, and that the Vermont law should go into effect as planned, without delay.

Food companies have had nearly two years to prepare for GMO labels, and the Vermont Attorney General has already announced that fines will not be levied against non-compliant companies until January 1, 2017.

That gives companies that are lagging behind a 6-month grace period to update their labels, during which time right of action suits cannot be filed against them. So truly, there’s only one reason to push for a delay, and that’s to get the law nullified by some other piece of legislation along the way.

Pro-GMO Senators in Weaker Position Than Ever Before

The Vermont labeling bill passed 28-2. Now, the senators who lost want to modify the bill before it goes into effect, threatening to open the bill up to a fight on the floor unless the deadline gets extended to 2018. But even if that would occur, they hardly stand a chance of winning.

This is because, they’re actually in a weaker position today than when the bill was originally passed two years ago.

For starters, in March 2015 the International Agency for Research on Cancer (IARC), which is the research arm of the World Health Organization (WHO), determined that glyphosate, the active ingredient in Monsanto’s Roundup herbicide, is a Class 2A “probable human carcinogen.”

This determination was based on evidence showing the popular weed killer can cause non-Hodgkin’s lymphoma and lung cancer in humans, along with “convincing evidence” it can also cause cancer in animals.

We also know that glyphosate use has dramatically increased as a direct result of GE crops, and that alone is a significant health concern that cannot be overlooked when discussing GMOs and GMO labeling.

Glyphosate Toxicity Is an Important Part of the GMO Labeling Discussion

Before GE crops, glyphosate was used sparingly, as it kills any plant it touches. This meant farmers could not apply it near their crops, lest they risk killing off their crops as well. It was only used where farmers wanted to kill all vegetation, such as between the rows in orchards or in industrial yards.

This all changed in 1996, when Monsanto’s so-called “Roundup Ready,” GE glyphosate-tolerant crops were introduced.

Since these crops are impervious to glyphosate’s toxic effects, farmers can spray the chemical onto their crops with abandon. And due to mounting weed resistance, that’s exactly what they’ve had to do. Since 1996, glyphosate use has risen nearly 15-fold.11

Since glyphosate was introduced in 1974, 1.8 million tons have been applied to U.S. fields, and two-thirds of that volume has been sprayed in the last 10 years.

Monsanto has also successfully promoted the use of Roundup on non-GE crops as a desiccant.12 Basically, the chemical is sprayed on crops right before harvesting to dry out the crop and allow farmers to harvest earlier — a technique that results in a higher profits as earlier harvest yields higher prices.

Contrary to the U.S., the EU Parliament is calling on the Commission to severely restrict the permitted usage of glyphosate, and to ban pre-harvest dessication in order to protect human health.13

Glyphosate use is in fact so excessive at this point that even organic farms are now plagued by glyphosate residues in their produce, even though it’s not actually sprayed on their farms. It drifts over from other farms.

In Vermont, herbicide use on corn increased by 39 percent since the advent of GE corn. Nitrogen fertilizer use has also increased by 17 percent. Moreover, nearly all — 99.4 percent to be exact — of the chemicals used on GE corn grown in Vermont are suspected hormone disruptors, capable of promoting cancer and birth defects.

All of these facts have a bearing on the GMO discussion, and add weight to the call for clear labeling. Vermont is the first state to pass a no-strings-attached GMO labeling law, and it needs to be implemented as planned.

Farm Subsidies Only Make the Rich Richer

While millions of taxpayer dollars will be spent to convince you of the merits of GMOs — which also means they’re promoting processed foods, since that’s where the majority of GE crops end up — little is being done to promote the growing of healthier foods like fresh fruits and vegetables on small farms.

A recent report14 by the Environmental Working Group (EWG) points out that no less than 50 American billionaires received at least $6.3 million in commodity support payments from farm bill programs between 1995 and 2014. Among them are David Rockefeller Sr., Commerce Secretary Penny Pritzker, Microsoft co-founder Paul Allen, and Charles Schwab. According to the EWG:

“[T]hese fat cats likely received even more subsidies through the federal crop insurance program … On average, taxpayers cover 62 percent of the cost of crop insurance premiums …

Of the 50 billionaires, 46 grow corn, soybeans, sorghum, cotton, rice and barley — commodities that are eligible for both traditional farm subsidies and crop insurance subsidies. Only two of the billionaires exclusively raise livestock, which aren’t eligible for subsidies but qualify for disaster assistance …”

In short, your tax dollars are spent to promote a dietary trend that leads to diabetes, heart disease and cancer, and now they will spend another $3 million to further the completely biased and scientifically unsupported idea that GMOs are safe and beneficial. Talk about misappropriation of funds! So what can you do? The greatest leverage we have as individuals is to vote for the system we want with every purchase.

Boycott GMA Members

For the past three years, there’s been an ongoing call to boycott GMA members  until they cancel their membership, and if you haven’t done so before, I urge you to consider getting serious about boycotting these traitor brands now.

The GMA has led the industry charge to undermine your right to know about GMOs, and they’ve even resorted to illegal measures to keep you in the dark. So really, by being members of the GMA, they are affiliated with a criminal element that destroys their reputation and severely undermines their integrity.

 

Hemp Bound: Dispatches from the Front Lines of the Next Agricultural Revolution

The stat sheet on hemp sounds almost too good to be true: its fibers are among the planet’s strongest, its seed oil the most nutritious, and its potential as an energy source vast and untapped. Its one downside? For nearly a century, it’s been illegal to grow industrial cannabis in the United States–even though Betsy Ross wove the nation’s first flag out of hemp fabric, Thomas Jefferson composed the Declaration of Independence on it, and colonists could pay their taxes with it. But as the prohibition on hemp’s psychoactive cousin winds down, one of humanity’s longest-utilized plants is about to be reincorporated into the American economy. Get ready for the newest billion-dollar industry.

In Hemp Bound:Dispatches from the Front Lines of the Next Agricultural Revolution, bestselling author Doug Fine embarks on a humorous yet rigorous journey to meet the men and women who are testing, researching, and pioneering hemp’s applications for the twenty-first century. From Denver, where Fine hitches a ride in a hemp-powered limo; to Asheville, North Carolina, where carbon-negative hempcrete-insulated houses are sparking a mini housing boom; to Manitoba where he raps his knuckles on the hood of a hemp tractor; and finally to the fields of east Colorado, where practical farmers are looking toward hemp to restore their agricultural economy―Fine learns how eminently possible it is for this misunderstood plant to help us end dependence on fossil fuels, heal farm soils damaged after a century of growing monocultures, and bring even more taxable revenue into the economy than its smokable relative.

Fine’s journey will not only leave you wondering why we ever stopped cultivating this miracle crop, it will fire you up to sow a field of it for yourself, for the nation’s economy, and for the planet.

Here’s What We Know About Cannabis And Cancer

This article was first published on IllegallyHealed.com.

The use of cannabis in the treatment of cancer is an emerging field in medicine. By staying up to date on the research and collaborating with other leaders in the field, physicians like my colleagues and myself can continue to meet the needs of real patients who choose not to wait for the federal government to stop obstructing human research on cannabis and cancer. Medical cannabis can be a part of an integrative plan that addresses your mind, body, spirit, family, and community.

Patients Are Reporting Relief From Cancer Symptoms And Treatment Side Effects

When used properly, cannabis can be a safe and effective treatment for nausea and vomiting caused by chemotherapy [1], chronic pain [2], and insomnia [3]. Animal studies have shown that cannabinoids can prevent the development of neuropathic pain, a common side effect of chemotherapy [4,5,6].

Via: OpenRangeStock | Shutterstock.

Via: OpenRangeStock | Shutterstock.

“Patients can often achieve significant improvements in quality of life with minimal side effects using very low doses of cannabis, in the range of 10-60mg per day (less than half a gram of herbs).”

— Dr. Dustin Sulak, Healer.com

 

Medical cannabis can help patients tolerate conventional cancer treatment, such as chemotherapy and radiation, and can be used as an adjunct to these treatments with low likelihood of drug interaction [7]. For patients with terminal cancer, cannabis offers numerous benefits in palliative care at the end of life [8].

A combination of tetrahydrocannabinol (THC), Cannabidiol (CBD), and other cannabinoids in various ratios can be used to fine-tune the benefits and minimize the psychoactive side effects of cannabis treatment.

The Use Of Cannabis To Fight Cancer And Promote Healing

In addition to the symptom relief and improvement in quality of life for cancer patients, cannabis has also demonstrated anti-cancer oncologic effects in numerous animal models [9]. A large body of anecdotal evidence suggests that human cancers also respond to treatment with cannabinoids [10,11].

Several patients have reported slowing or arresting the growth of tumors, while others have experienced full remission of aggressive cancers while using cannabis extracts [12].

To achieve these powerful anti-cancer effects, most patients require a higher dose than what is needed for symptomatic relief, often 200mg – 2,000mg cannabinoids per day, the equivalent of up to 1-2 ounces of herbal cannabis per week. While this level of treatment may be cost effective, especially if the cannabis is grown outdoors, acquiring this amount of medicine from a medical cannabis retailer could incur significant costs (see below). At these high doses, a knowledgeable medical provider must monitor the treatment to prevent side effects and interactions with conventional cancer treatment.

While any medical treatment carries certain risks, even high-dose cannabis is non-lethal and much safer than conventional chemotherapy, though the efficacy of high-dose cannabis for cancer has not been studied in humans.

If you decide to pursue a high-dose cancer treatment protocol, be prepared for the costs:

  • 1. Medical costs: Initial and follow-up visits with your oncologist, your cannabis specialist, and perhaps other complementary providers such as an acupuncturist or Reiki practitioner.
  • 2. Cannabis costs: Most adult patients will have to spend $100-$1,000 per week for a potent cannabis concentrate.
  • 3. Supplements and natural medicines: Most integrative oncologists and many cannabis specialists will recommend natural medicines that are not covered by health insurance to promote health, fight cancer, reduce side effects, and enhance the benefits of cannabis. Average cost $25-$100 per week.

Via: Wollertz | Shutterstock

Via: Wollertz | Shutterstock

“If you have cancer, and are interested in learning more about the use of cannabis, please make an appointment with a doctor or nurse practitioner that specializes in ‘cannabinoid medicine’. I am a board member of the Society of Cannabis Clinicians or contact my practice Integr8 Health in New England.”

 

I recommend reflecting on the following questions before your visit:

  • 1. What is your prognosis? How likely is success with conventional treatment?
  • 2. Are you interested in cannabis-based symptomatic treatment or a more aggressive anti-cancer approach?
  • 3. Are you willing to follow up with your oncologist to monitor the changes in your condition?
  • 4. How comfortable are you with mortality and death? Are you making fully informed medical decisions based on your personal preferences, or based on fear?

For a comprehensive review of the anticancer effects of cannabinoids, with numerous personal success stories, I suggest Justin Kander’s book, Cannabis for the Treatment of Cancer: The Anticancer Activity of Phytocannabinoids and Endocannabinoids,available online. I also welcome you to visit Healer.com to learn more about medical cannabis and how to use it therapeutically.

 

 

dr-dustin-sulakDr. Sulak is the founder of Healer.com and a renowned cannabis expert. He is the medical director of Integr8 Health which cares for over 18,000 patients and is a board member and research chair of the Society of Cannabis Clinicians. Dr. Sulak educates medical providers and patients on the clinical use of cannabis while continuing to explore the therapeutic potential of this ancient yet emerging medicine.

Sources:

1. Machado Rocha, Francisco C., et al. “Therapeutic use of Cannabis sativa on chemotherapy‐induced nausea and vomiting among cancer patients: systematic review and meta‐analysis.” European Journal of Cancer Care 17.5 (2008): 431-443.

2. Portenoy, Russell K., et al. “Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.” The Journal of Pain 13.5 (2012): 438-449.

3. Russo, Ethan B., Geoffrey W. Guy, and Philip J. Robson. “Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine.” Chemistry & Biodiversity 4.8 (2007): 1729-1743.

4. Ward, Sara Jane, et al. “Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice.” Anesthesia and Analgesia 113.4 (2011): 947.

5. Naguib, Mohamed, et al. “Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.” Anesthesia and Analgesia 114.5 (2012): 1104.

6. Burgos, Elisa, et al. “Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.” European Journal of Pharmacology 682.1 (2012): 62-72.

7. Stout SM, Cimino NM. Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systema0c review. Drug Metab Rev. 2014 Feb;46(1):86-95.

8. Green, Anita J., and Kay De‐Vries. “Cannabis use in palliative care–an examination of the evidence and the implications for nurses.” Journal of Clinical Nursing 19.17‐18 (2010): 2454-2462.

9. Sarfaraz, Sami, et al. “Cannabinoids for cancer treatment: progress and promise.” Cancer Research 68.2 (2008): 339-342.

10. Singh, Yadvinder, and Chamandeep Bali. “Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation.” Case Reports in Oncology 6.3 (2013): 585-592.

11. Kander, J. “Cannabis for the Treatment of Cancer: The Anticancer Activity of Phytocannabinoids and Endocannabinoids” 2015.

12. Gardner, F. “Doctors stress need to document anti-cancer effects of Cannabis ‘oil’.” O’Shaughnessy’s: The Journal of Cannabis in Clinical Practice. Winter/Spring 2013.

BREAKING NEWS: US Gov’t Admits Cannabis Cures Cancer

Posted by Nurse Mary-Jane on 02/05/2016 in Medical Marijuana

Location: United States | Source: National Cancer Institute

It's time to reschedule cannabis

The moment medical marijuana has been waiting for since California first passed laws legalizing the medicinal use of cannabis, in 1996, is finally here — the US government has, at last, admitted that marijuana has medical benefit. Yes, you heard right — the US government recently updated content pages on the National Cancer Institute’s (an official division of the US Department of Health) website to include information about, cannabis and cannabinoids.

Attempting to not draw too much attention to the update, the US National Cancer Institute quietly updated their website in January, admitting that cannabis and cannabinoids kill cancer without damaging the body’s normal cells. Considering that cannabis is a Schedule 1 drug, which according to the Controlled Substances Act of 1970, means that it holds NO MEDICINAL VALUE, how could such a unbelievable admission go unnoticed by mainstream media? After all this is the plant that has been demonized as the “gateway drug”, for the past 80 years — this is BREAKING NEWS!!

The pages include a section for both patients, and physicians, and covers topics ranging from the medical effects of cannabinoids, to preclinical studies conducted using cannabis or cannabinoids. Studies in mice and rats have shown that cannabinoids may inhibit the growth of a tumor by causing cell death, blocking cell growth, and blocking the development of blood vessels need by tumors to grow. While further animal and laboratory study’s have shown evidence that cannabinoids may be able to kill cancer cells while protecting normal cells.

Additional studies have shown that there is evidence of cannabinoids protecting against inflammation and cancer of the colon; may have anti-tumor effects; may be effective in stoping breast cancer; and may make chemotherapy more effective.

Also included, is commentary about how the US government distributed cannabis to patients on a case-by-case basis under the Compassionate Use Investigational Drug (IND) program between 1978 and 1992, despite while claiming that cannabis held no medicinal value. It goes on further to say that researchers, have studied how cannabinoids act on the brain and other parts of the body, and have discovered cannabinoid receptors (molecules that bind cannabinoids) in both brain cells, and nerve cells in other parts of the body, with further evidence of cannabinoid receptors on immune system cells, suggesting that cannabinoids may play a key role in immunity, too.

It also includes information on its effectiveness to stimulate an appetite, relieve pain, reduce inflammation, control nausea and vomiting, it’s anti-anxiety effects.

Since the early 1990’s physicians have been prescribing opioid medications at an ever-increasing, and alarming rate. Resulting in an epidemic far greater in evil, than any reefer madness. The US, is now battling to counter the out-of-control, critical state of prescription drug abuse that is plaguing all classes, ethnicities, and ages. It is estimated that 52 million people have used prescription pills for non-medical reasons at least once in their lifetime, including a overwhelming large number of young people. The National Institute on Drug Abuse (NIDA) conducted a survey called “Monitoring the Future”, which found that 1 in 12 high school seniors reported non-medical use and abuse of prescription pills, while rating Vicodin, and OxyContin, as the most commonly abused drugs by adolescents. In an effort to regain control of the pill-popping monster that has been pharmaceutically created, the US is clamping down on the physicians who have writing the prescriptions, enforcing a strict new protocol that is leaving only pain management physicians with the right to prescribe pain pills.

Which leaves us to wonder only one thing – could the federal government be getting ready to reschedule cannabis, allowing for the medical research and scientific study of pot?

Firstly as a solution, to curbing the pandemic of prescription abuse among people, and patients. Secondly as a peace offering, to the pharmaceutical super-giants grotesquely over-capitalizing on the current state of the nation — cannabis will open the door to a whole new pharmaceutical industry as compensation, and while this is not something we condone, the simple fact alone is enough to have the ensure that pharmaceutical lobbyists share our agenda. Thirdly, because President Obama promised to support and sign the CARERS ACT, legalizing the medicinal use of marijuana thereby allowing for its use by the Veterans Affairs, and the vets who repeatedly keep pleading for reform — Question: Why are our vets pleading? They are our veterans, the men and women who have risked their lives, to defend and protect ours. They shouldn’t need to ask – let alone still beg or plead! As a nation, we should respectfully give them anything they need to help ease their pain and suffering, as a result of their service.
And finally – and most importantly of all – because President Obama promised change, and congressional reform of medical cannabis if the states led the way. Considering that when Obama took office in 2009 there were already 14 legal medical marijuana states, and now there’s 23 with more on the way, while 4 states and the District of Columbia have altogether legalized the recreational adult-use of pot, its clear that the states have held up their end. Now, its time for the president to uphold his.

“I don’t think rescheduling is something that I would characterize as drastic,” said U.S. Rep. Earl Blumenauer (D-Oregon), one of the key members of Congress’s cannabis reform cabal. “If we were scheduling today, marijuana would not be Schedule I — or Schedule II. In fact, it may not be scheduled at all.”

“If we were scheduling from scratch and doing so based on scientific evidence, tobacco would be Schedule I. It’s an addictive killer,” he added

In support of medicla marijuana and it’s patients, everywhere:
PLEASE SHARE THIS BREAKING NEWS with as many people in your network, as you can. Help stop reefer maddness once and for all, and spread the word that the federal government has admitted the truth, about marijuana and its medicincal value.
Help PUSH President Obama to keep his promise and reschedule cannabis, for the greater good of us all!!
Time to reschedule marijuana

mCig Inc.: High On Smoke

|

49 comments

|

About: mCig, Inc. (MCIG), Includes: VTCQ

Informer Research
Hedge fund manager, long/short equity

Summary

No assets, operating income, or business plan, yet a $25 million valuation.

Hidden shares, fake partnerships, and a history of other shenanigans.

Company facing cash squeeze.

mCig Inc. (OTCQB:MCIG) is a failed e-cigarette company surviving on a cloud of smoke. mCig started as a simple e-cig brand that audaciously described itself as a “Technology Company“; now the company calls itself a “Cannabis Product Distributor,” despite having no distribution assets. With no cash or gross profits to speak of, the company has been using its inflated stock as a currency to cover an unexplainably massive overhead: five of the six million dollars of overhead expense the company spent over the past 2.5 years was paid in shares! But with the stock price collapsing, capital has become scarce: last quarter, the company was too cash-strapped to even pay for its inventories. The company has no credible business plan, is riddled with all sorts of shenanigans, and at the current $25 million market capitalization, is set for a sober crash.

No Buzz

MCIG still sells its e-cigarette, the mCig 4.0, but nearly three years after its launch, the product is an obvious flop. In a 2013 interview, mCig’s CEO Paul Rosenberg said that “intellectual property protection for these devices is important but secondary to being a first mover and developing brand recognition.” Fast forward three years later, mCig has neither intellectual property nor brand recognition.

Among the countless pages of e-cigs on amazon.com (NASDAQ:AMZN), the mCig is nowhere to be found. Maybe they sell the product directly through their website? A simple Google search for MCIG yields a barrage of websites hocking the stock, but none selling the product; telling. Google trends says that MCIG’s homepage has too little traffic to even track! Searches for the mCig product correlate almost exactly with the stock price – now on a precipitous decline. The lack of web traffic is especially ironic given the company is now marketing itself as an expert in SEO and SEM services.

Revenue has grown, but the outrageously hyped growth (a) was off of a stupidly low base, (b) came with a big gross margin decline, and (c) is suspicious given accounting irregularities. While conveniently obfuscated by the pointless Vitacig (OTCPK:VTCQ) spinoff, a simple cleanup of mCig’s standalone financials reveals oddities including massively negative Q4 2015 gross margins (same pattern at VitacCig – see discussion below). A theory: since MCIG aggressively reserves $0 for obsolescence and warranty reserves (see MCIG 10-Q), management may have been stuffing write-offs, product returns, or warranty claims in Q4. The accounting policies haven’t changed, so this year’s revenues could also be overstated. Also worth noting, last quarter the company switched auditors – from a Salt Lake City firm to a China focused firm, which is odd.

A Thin Cloud

With the e-cigarette a flop, MCIG is now supposedly ‘focusing’ on selling $50k cannabis grow rooms, initially called mCig CannaPods but recently renamedmCigPods. The renaming is not insignificant: after noticing the change (and the fact that the mCig logo was obviously Photoshopped on the product photo) we found and called the real CannaPods company. According to a CannaPods representative, CannaPods has no affiliation with mCig,has patents pending, and their lawyers are involved with the “MCIG Situation.”

In a recent press release, mCig seems to have touched on this change, chalking it up to an inevitable progression from Pods to proprietary products. This is balderdash: the company has nothing proprietary and – as discussed further below – mCig’s only progression has been the surfacing of one bogus deal after another. Add this one to the list.

On the company website, MCIG claims to have diversified into other business lines including:

As a side note, MCIG’s supposed affiliation with CodeKush.com – a domain troller – is also ironic considering MCIG.com is currently held hostage byanother domain troller. MCIG has had to settle for the ‘.org’ site – mcig.org

  • MCIG is now supposedly in the “Finance” business. Given the fact that mCig couldn’t even afford its $50k of inventories last quarter (see $28.8k advance from related party on latest cash flows statement), this is clearly a joke. Like a 2007 mortgage broker, the company claims to be offering loans with no pesky credit checks, documents, spending restrictions, or assets required (see program description below). Shareholders should pray that this ‘business’ never becomes real!

MCIG Business Cash Flow Loan Program Description: “Banks may require lengthy applications and documentation; stipulate how the capital is to be spent; or deny applications based on FICO criteria or asset collateralization requirements. Our flexible cash flow business loan program is perfect for businesses that are looking for something more than a conventional bank loan.”mcig.org/services/financing/

  • The company claims to be involved in a poorly reviewed rolling paper company called Blanks. Nowhere on Blanks’ website, or any MCIG filing, is this relationship mentioned.
  • mCig claims to have an exclusive marketing agreement with an oil extractor called Emotek Labs; yet Emotek seems to have their own marketing person on their company Facebook page.

All of this is flimsy, bogus, and misleading to shareholders, and it doesn’t stop there. According to the mcig.org About Us page, the company has “the industry’s largest sales team,” but in the company says in their latest MCIG 10-K that “as of April 30, 2015, we had no full-time employees.” While the company may have some ‘independent contractors’, a simple LinkedIn search for mCig Inc. shows only eight people ever affiliated with the company. Most are gone and only lasted a few months.

Over the past two and a half years, the company has spent over $6 million on overhead. Where have those expenses gone? The money was clearly not invested in the business: the company has no assets and over its entire life has only spent a whopping $53k on R&D and Advertising (see latest MCIG 10-K). Despite claims to have offices in multiple states and countries, the company has just this virtual office; likely the Bronze package at $99 per month. With no IP, assets, and infrastructure to speak of, the 10-K’s list of G&A items suggests that a majority of the expenses have been blown on Paul Rosenberg’s dining and entertainment budget; i.e. shareholders are effectively funding Rosenberg’s fun and games. Don’t expect anything in return.

High on Hype

Soon after mCig became public – via a reverse merger at the end of 2013 – the stock soared to an eye-popping $400 million valuation. Since then, the stock has dropped like a lead weight, only to be intermittently propped up by bouts of outrageously hyped press releases. Examples include bogus partnership and product announcements, moonshot revenue targets, and a seemingly endless stream of illusory opportunities.

The SEC even asked Rosenberg to tone it down in this letter. Below is a scorecard analyzing ten mCig announcements over the last two years, the result of each announcement, and the stock price moves around the news. While we can only speculate about the shenanigans going on around these stock price moves, we can know for sure that – since the company pays a vast majority of its expenses in stock – Rosenberg needs that high stock price in order to keep rolling. Let the hype flow!

Links to news articles:

Vapolution Acquisition: $1.3 million in sales

Rick Ross Partnership

New Product mCig+

Vitacig Spinoff

Strategic Partnership with Force Fuels

Climagrow Partnership

1.2mm order for CBD products

7-10mm FY16 Rev Guidance

Q2 16 Revenue Guidance: 850k

Grant County, WA Grower Facility Contract

1.25 million Vaporized

On January 23, 2014 mCig ‘purchased’ Vapolution for $1.25 million; mCig’s stock soared 52% on the news. mCig’s press release claimed that the transaction “set the stage for significant synergies,” and “consolidates an industry leader with over $1.3 million in sales.” But according to this SEC inquiry, the transaction was bogus: mCig acquired none of Vapolution’s assets (then what did it include? – inquired the SEC), plus allowed Vapolution to retain 100% control of its business, the first $110k of EBITDA each year, and an ability to rescind the transaction at any time until 2019! In effect, nothing was acquired!

Vitacig: Burnt Out

Last year, mCig spun-off its Vitacig business, and as discussed above, the spin helped cloud shenanigans at both companies (see chart below for same negative gross margin in Q4 15). Perhaps fogging-out the financials was the purpose of the spin, which seems pointless otherwise. Maybe the transaction provided some strategic or operational benefit? It appears not: in the three quarters post-spin, revenues have fallen off of a cliff (along with the stock), and the company has burnt through nearly all of its cash ($130k in total); only $3k remains. Earlier this week, the CEO wrote a letter announcing yet another re-launch of the Vitacig brand; don’t hold your breath.

More Puffing

In another press release this week, management claims to have used their ‘expertise’ from “hundreds of previous cultivation projects” to get involved in constructing growing facilities that would start at $100k but supposedly grow to $550k, and then $2.4 million. What do these numbers even mean for mCig? What does mCig even bring to the table? The company has nothing proprietary, has no building experience, and – as we discussed above – has been falsely masquerading as a distributor of CannaPods’ products. The press release goes on to mention that mCig “currently [has] over $6 million in construction contracts being negotiated.” The stock is up over 80% on this nonsense.

Just to shed a little more light on this ‘transaction’: mCig’s counterparty isTravis Nyman, who has a company called Evolution Design Concepts and ownsthis 21-acre property in Mattawa, Washington, where – as the release suggests – he plans to lease parcels to growers. Cue the trumpets, chatter about multimillion-dollar figures and voila – mCig’s market capitalization is up $12 million! Back on planet earth Travis Nyman is three years behind on this property’s taxes and spent two years trying to sell the property for less than $200k; obviously unsuccessfully. It is disingenuous and misleading for Paul Rosenberg to suggest that involvement in this scheme will somehow translate to millions for the company.

Secret Stash

Speaking of sneaky business, Rosenberg converted 207 million of his shares into preferred stock that does not show up on the register. This means the stock is actually 70% more expensive than it looks on the screen! In a 2013 Seeking Alpha interview, Rosenberg said, “My preferred shares cannot be converted back to common for a year so they are not currently part of the valuation.” This is pure malarkey and shows how lowly he thinks of his shareholders’ intelligence. He was also called out by the SEC for trying to not disclose that the shares are convertible. In reality – including his preferred shares, which can be converted at any time – there are 508 million shares outstanding, so at the current stock price the market capitalization is nearly $25 million! Someone must be smoking something!

The Blunt Truth

MCIG has no assets, IP, credible team, business plan, or operating income. Management has demonstrated a clear track record of failure, bogus acquisitions, deception, manipulation, and shenanigans. The company has only $100k left in cash; yet the market cap is still $25 million. Shareholders are effectively funding Paul Rosenberg’s antics and escapades as a wannabe cannabis executive, while in the meantime he manipulates the stock price and destroys value, ultimately at shareholders’ expense. This is a zero. Steer clear before it goes up in smoke.

Disclosure: I am/we are short MCIG.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: This report was written under a pseudonym, Informer Research. The author of this report may have short positions in the company covered herein and stands to realize gains in the event that the price of the stock declines. Following publication, the author may transact in the securities of the company, and may be long, short, or neutral at any time. The author of this report has obtained all information contained herein from sources they believe to be accurate and reliable. The author of this report makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any such information or with regard to the results to be obtained from its use. All expressions of opinion are subject to change without notice, and the author does not undertake to update or supplement this report or any of the information contained herein. This is not an offer to sell or a solicitation of an offer to buy any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction.

Editor’s Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.

Updates on Cannabis by state!

U.S. Cannabis Updates

FLORIDA

A man accused of running a marijuana grow operation in Southwest Miami-Dade is using the example of Colorado’s established medical and recreational marijuana industry as part of his defense. The man was growing 15 plants with an expected yield of 30 pounds of usable cannabis, but he insists that the cannabis was only to ease the pain of his wife, Maria Varona, who was diagnosed with cancer. Prosecutors claim that it was a sophisticated operation, with high-powered lights and carbon filters for the smell.

However, a witness for the defense, Bruce Vanaman, a Colorado cannabis businessman and cancer patient, testified that the operation was low-tech and amateur in comparison to Colorado’s sophisticated cannabis farms. “It’s a garden,” he told defense attorney Adam Bair.

Ms. Varona was first diagnosed with breast cancer in 2010 and used cannabis-infused products in Venezuela while undergoing treatment, but has had to travel to Colorado in order to maintain a supply of medical cannabis. Florida passed a law in 2014 which allows medicinal cannabis with low-THC and high-CBD content, but the state has not issued licenses for production yet.

MARYLAND

Nearly two and a half years after the passage of Maryland’s medical marijuana law, the Maryland Medical Cannabis Commission is ready to issue business licenses to medical marijuana dispensaries and cultivation centers. The state regulations will allow for 15 cultivation centers and 94 dispensaries, with two allowed per state Senate district. Although the program plans to issue the licenses within the next month, there is not a set date for when they will begin accepting applications. Medicinal cannabis is expected to be available to qualified patients by the end of 2016.

The implementation of the program is making county legislators nervous about the potential rise in crime, with many local legislators considering a ban on dispensaries. Counties are forbidden to prohibit legal businesses without special circumstances, and state Senator Robert Zirkin (D-Baltimore) has pulled out all of the stops with a new bill that would bar local governments from blocking medical cannabis access to qualifying patients – essentially, a ban on bans.

MICHIGAN

Michigan’s House Judiciary Committee just sent three bills to the full House floor for consideration that would officially legalize dispensaries, as well as cannabis-infused edibles. The Michigan Medical Marihuana Act was approved by voters in 2008, but the law does not make mention of medical dispensaries, nor of regulations on edibles or extracted oils and concentrates. The program has been fraught with issues due to the lack of definition in the law, with many dispensary owners operating without any legal protections, guidelines, or regulations.

The main piece of proposed legislature would introduce an eight percent excise tax and a mandatory system for tracking all cannabis products. This legislation would also create a Medical Marihuana State Board to oversee the program and issue the five different license types:
Grower
Processor
Provisioning center
Secure transporter
Safety compliance facility

NEW MEXICO

Albuquerque city council voted in a narrow 5-4 majority to make the possession of small amounts of cannabis a civil offense with a $25 fine (unless the person has a medical marijuana recommendation) instead of possible jail time. The committee also adopted a resolution to make cannabis possession the lowest priority for law enforcement in the city.

While it was found during the 2014 election that 60 percent of Bernadillo County supported cannabis decriminalization, unfortunately, not everyone in the state feels that way. Albuquerque Mayor Richard Berry has said that even if the House and Senate both pass the bill, he would veto the law just as he vetoed a similar decriminalization measure introduced last year, due to the conflict between state and federal law.

OREGON

Despite the legalization of cannabis in Oregon (for which sales will begin this week), it has come to light that more than $750,000 in funding from the DEA’s Domestic Marijuana Eradication/Suppression Program is being sent to police in Oregon for the purposes of searching for and destroying cannabis operations. The majority of the funds are spent on the use of helicopters to seek outdoor grow sites, although state records reflect a decrease in the number of cannabis plants destroyed per year, from 26,597 down to 16,067 plants. Each plant costs taxpayers approximately $60 to destroy.

Many of the previous growing operations that were discovered in Oregon were connected to violent Mexican drug cartels; however, legalization means that many criminal gangs are moving away from cannabis and focusing on trafficking other illegal drugs, such as heroin or methamphetamine. Jackson County Sheriff Corey Falls said of the funding, “When there were huge cartel problems, we needed that money. But now we don’t.”

WASHINGTON

Washington legalized recreational cannabis in 2012, but there appears to be an unexpected clause in the newest marijuana law, Senate Bill 5052, that is causing outrage and concern in Washington’s cannabis community. If a minor in Washington is caught using cannabis recreationally, he or she faces a felony conviction. The concern came to light when a prosecutor in Asotin County charged three teenagers with possession of cannabis. Instead of looking at a misdemeanor with a possibility of three months in jail, the teenagers faced a Class C felony, which carries the heavy maximum sentence of five years in jail.

Governor Jay Inslee’s office expressed surprise, and even the enforcement chief of the Washington State Liquor and Cannabis Board, Justin Nordhorn, was taken aback that the wording of the law does, in fact, specify that minors shall be charged with a felony for cannabis possession. The sponsor of the law, Senator Ann Rivers (R-La Center), said that the wording was intentional to help stymie the use of cannabis among youth. It is expected that the current cannabis regulations will be amended further in the upcoming legislative session.

UPDATE: The charges against the teens have been reduced to misdemeanors, and although two of the three teens had already pled guilty, the Asotin County prosecutor is seeking to reduce those charges.

International Cannabis Updates

UNITED KINGDOM

A newly formed cannabis law reform group called the National Cannabis Coalition will be headed up by Tom Lloyd, a former chief constable of the Cambridgeshire police. The new organization will encompass NORML UK, the UK Cannabis Social Clubs, and the United Patients Alliance, and the group will call for legal access to both recreational cannabis for adults and medicinal marijuana for patients who need it.

Lloyd plans to move the focus from grassroots protests to political campaigning and reforming UK drug policy. “A major problem in drug law reform, and the resistance to it, is that people look at people, whether they are heroin users or stoners, and think they are just not serious people,” said Lloyd, “The world is changing: Uruguay has now legalized it; you have got legal production in states in America; in half the states you can get medicinal cannabis. America is a very powerful player.”

The greatest challenge now will be to change the stereotype surrounding cannabis use and unite the many different cannabis advocates into one group with a common goal.

Men’s Wearhouse founder comes out in favor of pot legalization

You can count on one hand the number of chief executives of large companies who publicly support the legalization of marijuana. The list goes as follows:

John Mackey, co-CEO of Whole Foods Market; Richard Branson of the Virgin Group; billionaire financier George Soros; and Peter Lewis of Progressive Insurance (who was a longtime advocate before passing away in 2013).

Now, there’s a fifth CEO–George Zimmer, founder of Men’s Wearhouse, a company that fired him two years ago. He divulged to CNBC that he’s a cannabis aficionado of sorts.

Read More › How to legally invest in pot companies

“I’ve been smoking marijuana on a regular basis for about 50 years,” Zimmer said to CNBC, before joking, “As you can see, it’s really impacted me in a negative way.”

Zimmer gave the keynote speech Friday at the Cannabis World Congress & Business Expo in Los Angeles, pushing for legalization. “Everybody in the country knows what the truth here is, except the 535 people we elect to make these decisions in Washington, D.C.,” he told attendees. “It’s astounding.”

He’s throwing his support behind an initiative to legalize recreational marijuana in California next year, just as he supported the proposition that failed in 2010. No matter what form legalization might take, Zimmer said, “I think it’s important that we protect limited home cultivation without any government licensing, so whether it’s one plant or 10 plants, I don’t know, but I think that’s very important.”

‘Biggest con ever perpetrated’

George Zimmer, Men’s Wearhouse founder
Getty Images

George Zimmer, Men’s Wearhouse founder

Inside the Los Angeles Convention Center, he was surrounded by a variety of start-ups hoping to cash in on the legal pot craze. Zimmer said he looked into investing in one such company a year ago but decided not to—not least of which had to do with the Internal Revenue Service.

“There are still a lot of questions that are raised in terms of dispensaries, and the way the IRS does not allow normal business deductions.” He’s hoping that could change, and that at the very least, the federal government will remove marijuana from the list of Schedule I drugs.

“It’s treated like it was heroin,” he said. “Everybody’s who is in high school hears that and goes, ‘What are they talking about?'” He said it’s as if “The emperor’s not wearing any clothes. This is the biggest con that has been perpetrated on this country in the last century.”

Back in the menswear business

Marcus Lemonis, host of the CNBC show “The Profit”
Marcus Lemonis disses ‘Uber for tailors’

Meantime, Zimmer is also back in the men’s apparel business. He just launched an online suit and tuxedo rental site called Generation Tux. With the website, a groom or best man can submit measurements and rent formalwear for as little as $95.

“Our business model involves having the tuxedo arrive a week ahead of your event, and you to try it on. If there’s a mistake, we will FedEx another out to you, and if it’s still not right, we will dispatch a tailor to make it right,” he said. Zimmer has also started a tailoring company called zTailors, and he said both companies cost $50 million to start.

Generation Tux has a distribution center in Louisville, Kentucky, with 30,000 suits and tuxedos, and the company hopes to break even in 2017. If it takes off, Zimmer said they will need to raise more money. So would he ever consider going public again? “I wouldn’t go public if it [was] my call, but I’m not going to stand in the way if other people want to do that,” he said.


Men’s Wearhouse beats 2Q profit forecasts

It’s understandable. His ouster from Men’s Wearhouse was not pretty. Zimmer recalls having dinner with his family the night he was forced out. “It was a sort of uncomfortable quietness at the table,” he said.

“I said to my children, who were probably 10 and 12, I said, ‘Hey, look, Dad got fired,” he said. “It’s not going to mean anything to our lives, but I want you to understand that in life you’re going to have these adversities, and you have to overcome them, you have to learn to overcome all adversity in fact.”

Zimmer also said being fired was “probably the greatest thing that ever happened to me.” It forced him to learn about the latest technological developments in retail, which led to his new businesses.

“My best advice is, ‘You only lose if you don’t get back up off the ground. Every time you get back up, you win,” he said.

People United For Medical Marijuana / United For Care

Morgan & Morgan funds most of these funds!

A political committee spearheading a ballot initiative to legalize medical marijuana in Florida raised and spent more than $400,000 in August, according to a newly filed finance report. People United for Medical Marijuana, which also is known as United for Care, collected $437,220 during the month, with much of the money coming from the Orlando law firm headed by committee Chairman John Morgan. The Morgan Firm PA contributed about $363,000, the report shows. The political committee also spent $459,271 during the month, with about $352,000 of that amount going to PCI Consultants Inc., a California-based firm that does such things as gathering petition signatures. The committee had submitted 95,327 valid petition signatures to the state as of Friday morning, enough to trigger a Florida Supreme Court review of the proposed ballot wording. If the Supreme Court approves the wording, the committee would need to submit a total of 683,149 valid signatures to get the proposed constitutional amendment on the November 2016 ballot. A similar ballot measure in 2014 narrowly failed to get enough votes to pass.

It’s proven marijuana is the wonder drug for cancer

Scientists from the National Cancer Institute (US Department of Health) have confirmed that cannabis, or marijuana, does kill cancer cells, after a series of laboratory tests and speculations.

In its website, the institute wrote, ‘cannabis and cannabinoids may have benefits in treating the symptoms of cancer or the side effects of cancer therapies’ and also that ‘cannabis has been shown to kill cancer cells in the laboratory.’ The website also records that ‘cannabis and cannabinoids have been studied in the laboratory and the clinic for relief of pain, nausea and vomiting, anxiety, and loss of appetite.’ Here are 13 foods that help fight cancer.

Having said that, the researchers also stressed that marijuana has only shown these effects on mice, and are not yet ready to recommend the drug for human use in fighting cancer. Although Cancer Research pointed out that there is not yet enough evidence to determine whether cannabis can be effectively used for cancer treatment, but this could be a big moment in the battle against the disease. Know more about health benefits of marijuana.

This new development may pave the path for a nationwide legalization of marijuana!

Marijuana can actually stop the spread of cancer. It contains a chemical called cannabidiol that prevents the spread of cancer through your body. A study done by the California Pacific Medical Centre, San Francisco, found that cannabidiol (a potent component in weed) stops the deactivation of a gene called Id-1 that cancer cells use to spread throughout a person’s body. Cancer cells tend to make more copies of this gene than normal cells, which help them spread. The authors of this study took samples of breast cancer cells that have the highest level of expression of Id-1 and treated them with cannabidiol. They found that the cancerous cells decreased and were less aggressive in their spread. Subsequently, maybe smoking up might not be so bad.

Navigating Life When Things Get Hard

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Virtutibus igitur rectissime mihi videris et ad consuetudinem nostrae orationis vitia posuisse contraria. Te enim iudicem aequum puto, modo quae dicat ille bene noris. Sint modo partes vitae beatae. Cum praesertim illa perdiscere ludus esset. Duo Reges: constructio interrete. Quarum ambarum rerum cum medicinam pollicetur, luxuriae licentiam pollicetur.

Alterum significari idem, ut si diceretur, officia media omnia aut pleraque servantem vivere. Qui-vere falsone, quaerere mittimus-dicitur oculis se privasse; Non est enim vitium in oratione solum, sed etiam in moribus. Nummus in Croesi divitiis obscuratur, pars est tamen divitiarum. Si quicquam extra virtutem habeatur in bonis. Istam voluptatem perpetuam quis potest praestare sapienti? Nam ante Aristippus, et ille melius. Laboro autem non sine causa; Mihi, inquam, qui te id ipsum rogavi.